Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion description "[Since elevated expression levels of the epidermal growth factor receptor (EGF-R), in addition to that of c-Ha-ras, have been correlated with transitional cell carcinoma progression, we sought to determine whether up-regulation of the EGF-R had occurred in the invasive high ras expressors and if so, what functional significance this might have.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion evidence source_evidence_literature NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion SIO_000772 1868471 NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion wasDerivedFrom befree-20140225 NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_assertion wasGeneratedBy ECO_0000203 NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP647779.RAPgSMk3nXgHM-RofvP0jgw6LP8vn_2YnNPDrsQnXXRSU130_provenance.